OMNIAB, INC. Capital Expenditures Incurred but Not yet Paid
OMNIAB, INC. (OABI) reported Capital Expenditures Incurred but Not yet Paid of $47.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-03-04
- OMNIAB, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $52.00K.
- OMNIAB, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $53.00K, a 88.58% decline year-over-year.
- OMNIAB, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $77.00K, a 87.95% decline year-over-year.
- OMNIAB, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was -$155.00K.
- OMNIAB, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $47.00K, a 38.96% decline from fiscal 2024.
- OMNIAB, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $77.00K, a 88.46% decline from fiscal 2023.
- OMNIAB, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $667.00K, a 2931.82% increase from fiscal 2022.
- OMNIAB, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $22.00K, a 98.21% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $47.00K 10-K · filed 2026-03-04 | |||
| 2025-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $105.00K 10-Q · filed 2025-08-06 | $182.00K derived: sum of 3 quarters · filed 2026-03-04 | $27.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | $53.00K 10-Q · filed 2025-05-08 | $130.00K derived: sum of 2 quarters · filed 2026-03-04 | -$25.00K derived: sum of 3 quarters · filed 2026-03-04 | -$334.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$78.00K derived: sum of 2 quarters · filed 2026-03-04 | -$387.00K derived: sum of 3 quarters · filed 2026-03-04 | $77.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$464.00K derived: sum of 2 quarters · filed 2025-08-06 | $0.00 10-Q · filed 2024-11-12 | $639.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-06-30 | -$309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $155.00K 10-Q · filed 2025-08-06 | $794.00K derived: sum of 3 quarters · filed 2025-08-06 | $611.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $464.00K 10-Q · filed 2025-05-08 | $1.10M derived: sum of 2 quarters · filed 2025-05-08 | $920.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.03M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $456.00K derived: sum of 2 quarters · filed 2025-03-18 | $565.00K derived: sum of 3 quarters · filed 2025-03-18 | $667.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$74.00K derived: sum of 2 quarters · filed 2024-11-12 | $28.00K 10-Q · filed 2024-11-12 | -$3.51M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $211.00K 10-Q · filed 2024-08-08 | -$3.33M derived: sum of 3 quarters · filed 2024-08-08 | -$3.37M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $102.00K 10-Q · filed 2024-05-09 | -$3.44M derived: sum of 2 quarters · filed 2024-05-09 | -$3.48M derived: sum of 3 quarters · filed 2024-05-09 | -$2.39M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$3.58M derived: sum of 2 quarters · filed 2024-03-25 | -$2.49M derived: sum of 3 quarters · filed 2024-03-25 | $22.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.05M derived: sum of 2 quarters · filed 2023-11-09 | $3.56M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.60M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $2.51M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $1.23M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |